Nu Skin Enterprises Stock Beta
| NUS Stock | USD 12.70 0.34 2.75% |
Nu Skin Enterprises fundamentals help investors to digest information that contributes to Nu Skin's financial success or failures. It also enables traders to predict the movement of NUS Stock. The fundamental analysis module provides a way to measure Nu Skin's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nu Skin stock.
NUS | Beta |
Nu Skin Enterprises Company Beta Analysis
Nu Skin's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Nu Skin Beta | 1.1 |
Most of Nu Skin's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nu Skin Enterprises is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
NUS Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Nu Skin is extremely important. It helps to project a fair market value of NUS Stock properly, considering its historical fundamentals such as Beta. Since Nu Skin's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nu Skin's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nu Skin's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Nu Skin Enterprises has a Beta of 1.103. This is 10.33% lower than that of the Personal Care Products sector and 10.33% lower than that of the Consumer Staples industry. The beta for all United States stocks is notably lower than that of the firm.
NUS Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nu Skin's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nu Skin could also be used in its relative valuation, which is a method of valuing Nu Skin by comparing valuation metrics of similar companies.Nu Skin is currently under evaluation in beta category among related companies.
Nu Skin Institutional Holders
Institutional Holdings refers to the ownership stake in Nu Skin that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Nu Skin's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Nu Skin's value.| Shares | Aristotle Capital Boston, Llc | 2023-12-31 | 799.2 K | Northern Trust Corp | 2023-12-31 | 551.7 K | Goldman Sachs Group Inc | 2023-12-31 | 492.1 K | Norges Bank | 2023-12-31 | 459.8 K | Victory Capital Management Inc. | 2023-12-31 | 458.7 K | Two Sigma Advisers, Llc | 2023-12-31 | 446.9 K | Proshare Advisors Llc | 2023-12-31 | 437.8 K | Voloridge Investment Management, Llc | 2023-09-30 | 427.9 K | American Century Companies Inc | 2023-12-31 | 361.8 K | Blackrock Inc | 2023-12-31 | 8.5 M | Vanguard Group Inc | 2023-12-31 | 6.2 M |
Nu Skin returns are very sensitive to returns on the market. As the market goes up or down, Nu Skin is expected to follow.
NUS Fundamentals
| Return On Equity | 0.01 | ||||
| Return On Asset | 0.0461 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 938.41 M | ||||
| Shares Outstanding | 49.66 M | ||||
| Shares Owned By Insiders | 2.16 % | ||||
| Shares Owned By Institutions | 85.13 % | ||||
| Number Of Shares Shorted | 1.42 M | ||||
| Price To Earning | 10.70 X | ||||
| Price To Book | 0.72 X | ||||
| Price To Sales | 0.30 X | ||||
| Revenue | 1.97 B | ||||
| Gross Profit | 1.59 B | ||||
| EBITDA | 137.66 M | ||||
| Net Income | 8.6 M | ||||
| Cash And Equivalents | 264.73 M | ||||
| Cash Per Share | 7.69 X | ||||
| Total Debt | 607.33 M | ||||
| Debt To Equity | 0.59 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 16.61 X | ||||
| Cash Flow From Operations | 118.64 M | ||||
| Short Ratio | 1.61 X | ||||
| Earnings Per Share | 0.17 X | ||||
| Price To Earnings To Growth | 2.35 X | ||||
| Target Price | 15.5 | ||||
| Number Of Employees | 3.7 K | ||||
| Beta | 1.1 | ||||
| Market Capitalization | 609.88 M | ||||
| Total Asset | 1.81 B | ||||
| Retained Earnings | 1.87 B | ||||
| Working Capital | 373 M | ||||
| Current Asset | 706.39 M | ||||
| Current Liabilities | 407.6 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 3.09 % | ||||
| Net Asset | 1.81 B | ||||
| Last Dividend Paid | 1.56 |
About Nu Skin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nu Skin Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nu Skin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nu Skin Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nu Skin Piotroski F Score and Nu Skin Altman Z Score analysis. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for NUS Stock analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.88) | Dividend Share 1.56 | Earnings Share 0.17 | Revenue Per Share 39.612 | Quarterly Revenue Growth (0.07) |
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.